Author

Meng-Yi Li

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Ophiopogonin D Suppresses Non-Small Cell Lung Cancer Progression by Targeting Exosomal MALAT1 to Enhance Dendritic Cell Maturation.

Tumor-immune cell crosstalk critically shapes the progression of non-small cell lung cancer (NSCLC), yet the mechanisms underlying exosome-mediated immune suppression remain incompletely understood. Here, we identify a previously unrecognized exosomal lncRNA-mediated immunoregulatory axis targeted by the natural compou...

Qin-Feng Zhou, Yang Guo, Lei Wang et al. · Pharmacological Research · 0 citations

Review Open access Sep 2026

N6-methyladenosine as a potential epitranscriptomic immune rheostat during SARS-CoV-2 infection

A hypothesis-driven conceptual framework is provided for understanding how m6A integrates RNA fate control with antiviral immunity and immunopathology during SARS-CoV-2 infection, and how m6A shapes multiple layers of innate immune responses.

Xian-Feng Hui, Shuo-Xiang Gao, Shi-Huan Ding et al. · Frontiers in Immunology · 0 citations

Aug 2026

TRDMT1-dependent m5C modification of TLR4 mediates the protective effects of Shaoyao decoction in TNBS-induced Crohn's disease.

SYD can alleviate intestinal inflammation, inhibit apoptosis, and protect the intestinal barrier in the CD model, and mechanistic studies indicated that TRDMT1 and TLR4 were involved in the protective effects of SYD against CD-like colitis.

Yonghao Deng, Jing Wang, Meng-Yi Li et al. · International Immunopharmaco... · 0 citations